A common motif targets huntingtin and the androgen receptor to the proteasome

被引:13
作者
Chandra, Shweta [1 ,2 ]
Shao, Jieya [1 ,2 ]
Li, Jennifer X. [1 ,2 ]
Li, Mei [1 ,2 ]
Longo, Frank M. [3 ]
Diamond, Marc I. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[3] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
D O I
10.1074/jbc.M800467200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease derives from a critically expanded polyglutamine tract in the huntingtin (Htt) protein; a similar polyglutamine expansion in the androgen receptor (AR) causes spinobulbar muscular atrophy. AR activity also plays an essential role in prostate cancer. Molecular mechanisms that regulate Htt and AR degradation are not well understood but could have important therapeutic implications. We find that a pentapeptide motif (FQKLL) within the Htt protein regulates its degradation and subcellular localization to cytoplasm puncta. Disruption of the motif by alanine substitution at the hydrophobic residues increases the steady state level of the protein. Pulse-chase analyses indicate that the motif regulates degradation. A similar motif (FQNLF) has corresponding activities in the AR protein. Transfer of the Htt motif with five flanking amino acids on either side to YFP reduces the steady state YFP level by rendering it susceptible to proteasome degradation. This work defines a novel proteasome-targeting motif that is necessary and sufficient to regulate the degradation of two disease-associated proteins.
引用
收藏
页码:23950 / 23955
页数:6
相关论文
共 38 条
[31]   Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease [J].
Ravikumar, B ;
Vacher, C ;
Berger, Z ;
Davies, JE ;
Luo, SQ ;
Oroz, LG ;
Scaravilli, F ;
Easton, DF ;
Duden, R ;
O'Kane, CJ ;
Rubinsztein, DC .
NATURE GENETICS, 2004, 36 (06) :585-595
[32]   Protein aggregation and neurodegenerative disease [J].
Ross, CA ;
Poirier, MA .
NATURE MEDICINE, 2004, 10 (07) :S10-S17
[33]   The coactivator LXXLL nuclear receptor recognition motif [J].
Savkur, RS ;
Burris, TP .
JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (03) :207-212
[34]   The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions [J].
Schaufele, F ;
Carbonell, X ;
Guerbadot, M ;
Borngraeber, S ;
Chapman, MS ;
Ma, AAK ;
Miner, JN ;
Diamond, MI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (28) :9802-9807
[35]   Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic [J].
Takahashi, Toshiaki ;
Kikuchi, Shinya ;
Katada, Shinichi ;
Nagai, Yoshitaka ;
Nishizawa, Masatoyo ;
Onodera, Osamu .
HUMAN MOLECULAR GENETICS, 2008, 17 (03) :345-356
[36]   Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein [J].
Taylor, JP ;
Tanaka, F ;
Robitschek, J ;
Sandoval, CM ;
Taye, A ;
Markovic-Plese, S ;
Fischbeck, KH .
HUMAN MOLECULAR GENETICS, 2003, 12 (07) :749-757
[37]   Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins [J].
Venkatraman, P ;
Wetzel, R ;
Tanaka, M ;
Nukina, N ;
Goldberg, AL .
MOLECULAR CELL, 2004, 14 (01) :95-104
[38]   Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation [J].
Waelter, S ;
Boeddrich, A ;
Lurz, R ;
Scherzinger, E ;
Lueder, G ;
Lehrach, H ;
Wanker, EE .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1393-1407